arrow
返回

Minimum sample size for developing a multivariable prediction model: Part I – Continuous outcomes

delete2018-10-22
delete0
PRE
AI
DOI:10.1002/sim.7993delete
delete原文链接
delete原文求助
delete分享
delete收藏
摘要

摘要

En 中文
In the medical literature, hundreds of prediction models are being developed to predict health outcomes in individuals. For continuous outcomes, typically a linear regression model is developed to predict an individual's outcome value conditional on values of multiple predictors (covariates). To improve model development and reduce the potential for overfitting, a suitable sample size is required in terms of the number of subjects (n) relative to the number of predictor parameters (p) for potential inclusion. We propose that the minimum value ofnshould meet the following four key criteria: (i) small optimism in predictor effect estimates as defined by a global shrinkage factor of≥0.9; (ii) small absolute difference of≤0.05 in the apparent and adjustedR2; (iii) precise estimation (a margin of error≤10% of the true value) of the model's residual standard deviation; and similarly, (iv) precise estimation of the mean predicted outcome value (model intercept). The criteria require prespecification of the user's chosenpand the model's anticipatedR2as informed by previous studies. The value ofnthat meets all four criteria provides the minimum sample size required for model development. In an applied example, a new model to predict lung function in African‐American women using 25 predictor parameters requires at least 918 subjects to meet all criteria, corresponding to at least 36.7 subjects per predictor parameter. Even larger sample sizes may be needed to additionally ensure precise estimates of key predictor effects, especially when important categorical predictors have low prevalence in certain categories.
AI总结

AI总结

对已上传原文的论文进行重点信息的提取,主要内容包括:简要概述、研究摘要、背景介绍、关键亮点、图文解析、展望与总结。

期刊

暂无期刊信息

机构

暂无机构信息
引用论文

引用论文

暂无论文信息